We are live on ! Find out more
CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.67B
1-Year Est. Return 89%
This Fund
S&P 500
This Quarter Est. Return
-0.32%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$238M
AUM Growth
-$257K
Cap. Flow
+$12.2M
Cap. Flow %
5.15%
Top 10 Hldgs %
35.07%
Holding
477
New
382
Increased
34
Reduced
30
Closed
12

Top Buys

Rank Stock Value
1
HD icon
Home Depot
HD
+$3.72M
2
AMZN icon
Amazon
AMZN
+$3.54M
3
NKE icon
Nike
NKE
+$3.34M
4
PG icon
Procter & Gamble
PG
+$3.32M
5
COST icon
Costco
COST
+$3.26M

Top Sells

Rank Stock Value
1
JD icon
JD.com
JD
+$5.83M
2
ZTO icon
ZTO Express
ZTO
+$5.15M
3
EDU icon
New Oriental
EDU
+$4.58M
4
LI icon
Li Auto
LI
+$4.42M
5
CTLT
CATALENT, INC.
CTLT
+$3.94M

Sector Composition

Rank Sector Weight
1 Technology 36.45%
2 Consumer Discretionary 23.79%
3 Healthcare 23.76%
4 Communication Services 3.6%
5 Consumer Staples 3.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SYNH
126
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$45K 0.02%
+961
New +$62.1K
BEAM icon
127
Beam Therapeutics
BEAM
$2.76B
$43K 0.02%
+895
New +$51.1K
GBT
128
DELISTED
Global Blood Therapeutics, Inc.
GBT
$43K 0.02%
+632
New +$34.9K
ITCI
129
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$41K 0.02%
+884
New +$46.2K
BPMC
130
DELISTED
Blueprint Medicines
BPMC
$37K 0.02%
+559
New +$35.9K
MRTX
131
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$36K 0.02%
+521
New +$38.6K
DNLI icon
132
Denali Therapeutics
DNLI
$4.04B
$35K 0.01%
+1,155
New +$37.5K
STAA icon
133
STAAR Surgical
STAA
$1.27B
$35K 0.01%
496
+360
+265% +$30.8K
CCXI
134
DELISTED
ChemoCentryx, Inc.
CCXI
$35K 0.01%
+673
New +$27.8K
ALKS icon
135
Alkermes
ALKS
$8.44B
$34K 0.01%
+1,538
New +$40K
PTCT icon
136
PTC Therapeutics
PTCT
$6.06B
$34K 0.01%
+670
New +$32.8K
ARWR icon
137
Arrowhead Research
ARWR
$12.3B
$33K 0.01%
+992
New +$40K
MRVI icon
138
Maravai LifeSciences
MRVI
$861M
$31K 0.01%
+1,232
New +$30.9K
FOLD
139
DELISTED
Amicus Therapeutics
FOLD
$27K 0.01%
+2,627
New +$29.3K
PRTA icon
140
Prothena Corp
PRTA
$475M
$27K 0.01%
+439
New +$13.9K
RARE icon
141
Ultragenyx Pharmaceutical
RARE
$2.65B
$27K 0.01%
+656
New +$33.7K
ABCL icon
142
AbCellera Biologics
ABCL
$3.18B
$26K 0.01%
+2,670
New +$29.3K
ACAD icon
143
Acadia Pharmaceuticals
ACAD
$5.07B
$25K 0.01%
+1,515
New +$24.5K
HRMY icon
144
Harmony Biosciences
HRMY
$2.32B
$25K 0.01%
+554
New +$27K
INSM icon
145
Insmed
INSM
$28.9B
$24K 0.01%
+1,124
New +$26.9K
VIR icon
146
Vir Biotechnology
VIR
$1.52B
$24K 0.01%
+1,242
New +$31.6K
PCRX icon
147
Pacira BioSciences
PCRX
$945M
$23K 0.01%
+429
New +$23.9K
RLAY icon
148
Relay Therapeutics
RLAY
$4.4B
$23K 0.01%
+1,020
New +$22.4K
RXDX
149
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$23K 0.01%
+383
New +$17.5K
ARVN icon
150
Arvinas
ARVN
$580M
$22K 0.01%
+498
New +$24.2K
4 5
6
7 8

Similar funds

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
JPM
JANA Partners Management New York $1.67B AUM 1.66% 1-Year Est. Return
CPO
Cerity Partners OCIO New York $1.67B AUM 13.22% 1-Year Est. Return
LCI
L1 Capital International Sydney NSW 2000, Australia $1.68B AUM 9.83% 1-Year Est. Return
GWM
GDS Wealth Management Flower Mound, Texas $1.66B AUM 18.11% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return
RMC
Ribbit Management Company Palo Alto, California $1.68B AUM 40.61% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return

China Universal Asset Management Company's Q3 2022 Portfolio in Review

As of Q3 2022, China Universal Asset Management Company held 477 positions worth $238M, down 0.11% from $238M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

China Universal Asset Management Company deployed $12.2M of net new capital in Q3 2022, opening 382 new positions and adding to 34 existing holdings. Its largest new stake was Home Depot: 12,599 shares worth $3.48M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 39% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was JD.com, an estimated $5.83M trimmed.

  • China Universal Asset Management Company's largest Q3 2022 buy was Home Depot: 12,599 shares worth $3.48M.
  • China Universal Asset Management Company added most to Amazon in Q3 2022, an estimated $3.54M increase.
  • China Universal Asset Management Company's biggest Q3 2022 reduction was JD.com, cutting an estimated $5.83M.
  • China Universal Asset Management Company fully exited ZTO Express in Q3 2022, selling an estimated $5.15M.
  • China Universal Asset Management Company's ten largest holdings make up 35% of its $238M portfolio in Q3 2022.
  • China Universal Asset Management Company opened 382 new positions and closed 12 in Q3 2022.
  • China Universal Asset Management Company's portfolio value fell 0.11% quarter-over-quarter to $238M.

Based on China Universal Asset Management Company's 13F filing for Q3 2022, filed 21 Oct 2022.